UiPath Inc PATH shares have traded lower in 2026, despite a strong earnings report in December. Shares could be volatile this week with the company reporting fourth-quarter financial results Wednesday ...

UiPath Inc. PATH shares have slipped 11% in the past three months, in contrast to the industry’s 15% increase. This analysis reviews PATH’s recent performance and assesses whether the stock offers a ...

UiPath announces agentic AI solutions for healthcare revenue cycle management at ViVE 2026, targeting medical records review, claim denials and prior authorization. The company argues that ...

UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. 10 stocks we like ...